2026年9月25日星期五
M
寰宇通鑑
グローバル速報
Talent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei AsiaTalent shortage emerges as tech's biggest bottleneck in AI expansion boom— 日经 Nikkei AsiaJapan's JFE Engineering, startups bet on Philippine renewable energy— 日经 Nikkei AsiaTaiwan's ruling DPP rethinks nuclear power opposition in AI era— 日经 Nikkei AsiaTokyo commercial land prices jump to 33-year high as remote work ebbs— 日经 Nikkei AsiaJapan Air Self-Defense Force confirms Global Hawk drone crash— 日经 Nikkei AsiaJapan trading house lobby chief urges stronger yen despite sector windfall— 日经 Nikkei AsiaUK eyes role in Vietnam infrastructure boom with $2.5bn metro financing— 日经 Nikkei AsiaAustralia's rising far-right leader raises alarm over China's EV influx— 日经 Nikkei Asia

Traumatic intracranial lesion prevalence in CT-imaged adults with mild traumatic brain injury receiving dual versus single antiplatelet therapy: a two-center cohort study

出典 Nature 医学研究9 日前
内容の要約

Traumatic intracranial lesion prevalence in CT-imaged adults with mild traumatic brain injury receiving dual versus single antiplatelet therapy: a two-center cohort study

当サイトはタイトルと要約のインデックスのみを提供しています。完全なコンテンツと著作権はすべて元の配信元に帰属します。原文リンクをクリックしてご覧ください。

原文へ
所属チャンネル
健康
所属地域
グローバル視点
原文の言語
English
項目番号
health-14725d2d

Comments 0 comments

No comments yet. Be the first.

Traumatic intracranial lesion prevalence in CT-imaged adults with mild traumatic brain injury receiving dual versus single antiplatelet therapy: a two-center cohort study · 寰宇通鑑